Commentary Open Access
Volume 2 | Issue 4 | DOI: https://doi.org/10.33696/immunology.2.032
CRISPR Taking the Front Seat in Immunotherapy
Saad S. Kenderian1,2,3,4, Andrew D. Badley4,5,*
- 1T Cell Engineering, Mayo Clinic, Rochester, MN, USA
- 2Division of Hematology, Mayo Clinic, Rochester, MN, USA
- 3Department of Immunology, Mayo Clinic, Rochester, MN, USA
- 4Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA
- 5Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA
Corresponding Author
Andrew Badley, badley.andrew@mayo.edu
Received Date: February 07, 2020
Accepted Date: May 04, 2020
Kenderian SS, Badley AD. CRISPR Taking the Front Seat in Immunotherapy. J Cell Immunol. 2020; 2(4): 143-148.
Copyright: © 2020 Kenderian SS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Chimeric Antigen Receptor CAR NK Cells Emerging Immunotherapy for the Treatment of Cancer
Although NK cells are recognized as effector lymphocytes of the innate immune system, they also regulate the adaptive immune response by releasing inflammatory cytokines and developing immunological memory. Unlike other lymphocytes such as T or B cells, NK cells do not express rearrangeable, antigen-specific receptors.
Emerging Role of TRPML1 Mucolipin Endolysosomal Channel in Cancer
The transient receptor potential mucolipin 1 (TRPML1) is an endolysosomal channel belonging to the TRP family. Clinically, mutations of TRPML1 have been responsible for a severe lysosomal storage disorder called mucolipidosis type IV.
Circulating Cell-Free RNA: A New Perspective for Endometrial Cancer
In order to implement the knowledge of cancer to monitor its evolution and setting, in the last decade, new minimally invasive and repeatable samples collection have been developed such as liquid biopsy. Cancer biomarkers originating from tumors can represent the molecular status of the tumor or its metastases which release them directly into body fluids or indirectly due to disruption of tumor/metastatic tissue. These biomarkers are detectable in liquid biopsy.
Deubiquitinase as Potential Targets for Cancer Immunotherapy
During the last few decades, immunotherapy is considered to be an important approach to help our immune system to fight various kinds of diseases, such as tumor. Sometimes, it works very well for some types of cancers, for example: bladder cancer, colorectal cancer, breast cancer and lymphoma.
Role of the Gut Microbiome in the Modulation of Cancer Immunotherapy Response
The gut microbiome or gut flora is a vast community of microorganisms such as bacteria, viruses, protozoa, and fungi that inhabit the digestive tract of the human and other animals. In the human body, bacterial species colonize into the oral cavity, skin, vagina, and placenta, however, the largest population of microorganisms resides in the intestine. The majority of gut microbiota belong to the phyla Firmicutes, Bacteroidetes, Proteobacteria and Actinobacteria.